KEVIN LUKS: Open Payments
NPI 1235738659 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 17 payments from 10 companies in 2025. Trend: 2023 $129 · 2024 $394 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| PFIZER INC. | 4 | $65 |
| MERZ NORTH AMERICA, INC. | 1 | $41 |
| Amgen Inc. | 2 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Exact Sciences Corporation | 1 | $25 |
| Eisai Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
Products named: CAPLYTA, PAXLOVID, Xeomin, OTEZLA, TZIELD, Cologuard Collection Kit, Leqembi, FARXIGA.
Industry payments across FL — which companies pay providers there.
